首页> 美国卫生研究院文献>Springer Open Choice >The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE EUROPA and PROGRESS Trials

【2h】

The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE EUROPA and PROGRESS Trials

机译：培哚普利基于ACE抑制剂的治疗方案对29463例血管疾病患者的β-受体阻滞剂使用的影响：结合ADVANCEEUROPA和PROGRESS试验的个人数据进行分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

IntroductionIn everyday practice, angiotensin converting enzyme inhibitors and beta-blockers are cornerstone treatments in patients with (cardio-)vascular disease. Clear data that evaluate the effects of the combination of these agents on morbidity and mortality are lacking.

机译：简介在日常实践中，血管紧张素转换酶抑制剂和β受体阻滞剂是患有（心血管）疾病的患者的基石疗法。缺乏评估这些药物联合使用对发病率和死亡率影响的明确数据。

著录项

期刊名称 Springer Open Choice
作者
J. J. Brugts; M. Bertrand; W. Remme; R. Ferrari; K. Fox; S. MacMahon; J. Chalmers; M. L. Simoons; E. Boersma;
展开▼
作者单位

展开▼
年(卷),期 -1(31),4
年度 -1
页码 391–400
总页数 10
原文格式 PDF
正文语种
中图分类外科学;
关键词
ACE-inhibitor Perindopril Beta-blocker Hypertension Prevention Vascular disease;

机译：ACE抑制剂;培哚普利;β受体阻滞剂;高血压;预防;血管疾病;

相似文献

外文文献
中文文献
专利

1. The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials [J] . Brugts J. J., Bertrand M., Remme W., Cardiovascular drugs and therapy . 2017,第4期

机译：基于肝肾上普利的Ace抑制剂方案与β-阻滞剂在29,463例血管疾病患者中使用的治疗效果：提前，欧罗巴和进步试验的个体数据的综合分析
2. The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials. [J] . Brugts JJ, Ninomiya T, Boersma E, European Heart Journal: The Journal of the European Society of Cardiology . 2009,第11期

机译：基于血管紧张素转换酶抑制剂的治疗方案在血管疾病或高血管疾病风险患者中的治疗效果的一致性：对ADVANCE，EUROPA和PROGRESS试验的个体数据进行综合分析。
3. The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials [J] . Jasper J. Brugts1* Toshiharu Ninomiya2 Eric Boersma1 Willem J. Remme3 Michel Bertrand4 Roberto Ferrari5 Kim Fox6 Stephen MacMahon2 John Chalmers2 and Maarten L. Simoons1 European Heart Journal . 2009,第11期

机译：基于血管紧张素转换酶抑制剂的治疗方案在血管疾病或高血管疾病风险患者中的治疗效果的一致性：对ADVANCE，EUROPA和PROGRESS试验的个体数据进行综合分析
4. Development and testing of prediction models for end stage kidney disease patient nonadherence to renal replacement treatment regimens utilizing big data and healthcare informatics [C] . Yue Jiao, Geary Dan, Chaudhuri Sheetal, IEEE International Conference on Bioinformatics and Biomedicine . 2015

机译：利用大数据和医疗信息学开发和测试终末期肾病患者不遵守肾脏替代治疗方案的预测模型
5. Evidence-based treatment for individuals: Role of subgroup analysis and n-of-1 trials [D] . Gabler, Nicole Bloser 2010

机译：个体的循证治疗：亚组分析和N-1次试验的作用
6. Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study [O] . Andrew Briggs, Borislava Mihaylova, Mark Sculpher, 2007

机译：使用EUROPA研究的数据培哚普利降低稳定型冠心病患者心血管事件的成本效益
7. The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials [O] . Brugts, Jasper, Bertrand, Michel, Remme, Willem, 2017

机译：培哚普利基于ACE抑制剂的治疗方案对29,463例血管疾病患者的β-受体阻滞剂使用的影响：结合ADVANCE，EUROPA和PROGRESS试验的个人数据进行分析

The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE EUROPA and PROGRESS Trials

摘要

著录项

相似文献

相关主题

期刊订阅